25010: OU Brain and Spine Tumor Symposium (March 28-29, 2025)

Friday, March 28, 2025, 6:00 PM - Saturday, March 29, 2025, 4:02 PM CST, Nicholson Conference Center, 940 NE 13th Street, 5th Floor, Oklahoma City, OK

Join OU Health and the College of Medicine for the Inaugural Oklahoma Brain and Spine Tumor Symposium, a regional conference aimed at healthcare professionals involved in the care of patients with brain and spine tumors. This conference is designed to foster knowledge and collaboration between providers to improve the care of Oklahomans with benign, malignant, and secondary brain and spine tumors.

 

Download Announcement

1. Understand the neuro-oncology environment in Oklahoma and identify where practice gaps may exist.
2. Examine the contemporary surgical and medical management of pediatric brain tumors.
3. Describe the contemporary surgical and medical management of secondary malignant tumors to the spine.
4. Apply the contemporary use of advanced radiological techniques in the diagnosis and management of glioma.
5. Assess the impact of genomics on the management and prognosis of meningioma.
6. Explore the contemporary surgical and medical management of both low- and high-grade glioma.
7. Recognize the overlap between neurosurgery, medical neuro-oncology, and radiation oncology and understand when referral to tertiary care is appropriate.
8. Outline the intersection of surgery and radiation treatment in the management of brain metastases.
9. Differentiate the role of surgery and radiosurgery in the management of vestibular schwannoma.

1. Understand the neuro-oncology environment in Oklahoma and identify where practice gaps may exist.
2. Examine the contemporary surgical and medical management of pediatric brain tumors
3. Describe the contemporary surgical and medical management of secondary malignant tumors to the spine.
4. Apply the contemporary use of advanced radiological techniques in the diagnosis and management of glioma.
5. Assess the impact of genomics on the management and prognosis of meningioma.
6. Explore the contemporary surgical and medical management of both low- and high-grade glioma
7. Recognize the overlap between neurosurgery, medical neuro-oncology, and radiation oncology and understand when referral to tertiary care is appropriate.
8. Describe the intersection of surgery and radiation treatment in the management of brain metastases.
9. Differentiate the role of surgery and radiosurgery in the management of vestibular schwannoma.

1. Understand the neuro-oncology environment in Oklahoma and identify where practice gaps may exist.
2. Examine the contemporary surgical and medical management of pediatric brain tumors
3. Describe the contemporary surgical and medical management of secondary malignant tumors to the spine.
4. Apply the contemporary use of advanced radiological techniques in the diagnosis and management of glioma.
5. Assess the impact of genomics on the management and prognosis of meningioma.
6. Explore the contemporary surgical and medical management of both low- and high-grade glioma
7. Recognize the overlap between neurosurgery, medical neuro-oncology, and radiation oncology and understand when referral to tertiary care is appropriate.
8. Describe the intersection of surgery and radiation treatment in the management of brain metastases.
9. Differentiate the role of surgery and radiosurgery in the management of vestibular schwannoma.

Registration
MD/DO/PhD - $0
Resident - $0
Physician Associate - $0
Nurse (APRN, CNS, CRNA, LPN, NP, RN, etc.) - $0
Medical Student - $0
Other Healthcare Professional - $0

Event Details
Dates, Times, and Locations:
Friday, March 28, 2025 - 6:00 - 8:00 p.m. (Opening Reception - Colcord Hotel, 15 N. Robinson Ave., Oklahoma City, OK, 73102)
Saturday, March 29, 2025 - 7:00 a.m. - 4:00 p.m. (Nicholson Tower, Dean H. Gandy Auditorium, 1000 NE 13th St., Oklahoma City, OK 73104)

The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education 
ANCC Accreditation Statement: 
OU Medicine, Inc. is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

5.75 CNE contact hours will be awarded for meeting the following criteria: 90% attendance of conference, completion and submission of evaluation form.

Mitigation Statement: The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

University of Oklahoma Equal Opportunity / Non-Discrimination Statement: The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, housing, services in educational programs or activities, or health care services that the university operates or provides.
 
To file a grievance related to the non-discrimination policy, report sexual misconduct, and/or file a formal complaint of sexual misconduct, please utilize the reporting form at link.ou.edu/reportingform.
 
Inquiries regarding non-discrimination policies may be directed to the Office(s) of Institutional Equity as may be applicable – Norman campus: (405) 325-3546/3549, Health Sciences Center: (405) 271-2110, or OU-Tulsa Title IX Office: (918) 660-3107. Additionally, individuals may visit www.ou.edu/eoo.

Accommodation Statement:
Accommodations on the basis of disability are available by contacting Emily Tally at (405) 271-4912, Ext. 46141 or [email protected] as soon as possible.

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a ineligible company, which is used to pay all or part of the costs of a CME activity.  An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure: 
It is the policy of the University of Oklahoma College of Medicine that the faculty and presenters identify all financial relationships with ineligible companies relating to the topics of this educational activity, and also disclose discussions of off-label or investigational drugs/devices and/or therapies during their presentation(s). 

AMA PRA Category 1 Credits™ (5.75 hours), ANCC Nursing Contact Hours (5.75 hours), Non-Physician Attendance (5.75 hours)

Mitigation of Relevant Financial Relationships

The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.